Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Peripheral Vascular Disease
Trial Information
A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.
Status: Recruiting
Protocol Number: DECREASE-VI
Sponsor:
Company Division: Diagnostic
Official Scientific Title: A prospective study to assess the screening value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for the identification of patients that benefit from additional cardiac testing prior to vascular surgery.
Brief Summary: The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.
Study Phase: N/A
Study Design / Study Details:
- Purpose:
- Allocation: Non-Randomized
- Masking: Open Label
- Control: Historical
- Assignment: Parallel
- Endpoints:
Study Type:
Interventional
Condition: Peripheral Vascular Disease
Intervention Type: Diagnostic Test
Intervention Name: ELECSYS®proBNP
Primary Outcome:
Key Secondary Outcomes:
Inclusion Criteria:
- adult patients, ≥18 years of age;
- patients with peripheral vascular atherosclerosis, scheduled for vascular surgery.
Exclusion Criteria:
Gender: Males or Females
Age Limits: Min: 18 Years
Accepts Healthy Volunteers: No
Anticipated Start Date: February, 2007
Trial Registration Date: 08/21/2007
Date Last Updated: 08/28/2007
Link To Trial Results
E-mail: genentechclinicaltrials@druginfo.com
Research Site:
Located In:
Zwolle 8011 JW
Netherlands
Phone: 888-662-6728 (U.S. Only)
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
